Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Daniel R. Chevallard currently holds 12,886 shares of LENZ Therapeutics, Inc. (LENZ), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Daniel R. Chevallard has been a net buyer of LENZ stock. They have purchased $214.3K and sold $83.7K worth of shares.
Daniel R. Chevallard's most recent insider trade was on Mar 27, 2026, when they purchased 7,500 shares at $8.57 per share.
Daniel R. Chevallard serves as Executive at LENZ Therapeutics, Inc. (LENZ). They have executed 33 insider transactions totaling $298.0K over their tenure at the company.
Daniel R. Chevallard holds the position of Executive at LENZ Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Daniel R. Chevallard has shown a buying trading pattern, with $214.3K in total purchases and $83.7K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Daniel R. Chevallard was on Mar 27, 2026, when they purchased $64.3K worth of LENZ shares. This transaction involved 7,500 shares at $8.57 per share.
Daniel R. Chevallard currently owns 12,886 shares of LENZ Therapeutics, Inc. (LENZ), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Daniel R. Chevallard's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Daniel R. Chevallard has 33 Form 4 filings on record as an insider at LENZ Therapeutics, Inc..
Set alerts for Daniel R. Chevallard and 40,000+ other insiders.